Key points of EASL Clinical Practice Guidelines on hepatitis delta virus （2023）
10.3969/j.issn.1001-5256.2023.11.007
- VernacularTitle:《2023年欧洲肝病学会临床实践指南：丁型肝炎病毒》意见要点
- Author:
Huimin LIU
1
;
Wenting CHEN
1
;
Shilian LI
1
;
Hongmei GONG
1
;
Qing. MAO
1
Author Information
1. Institute of Infectious Diseases of PLA， Southwest Hospital， Army Medical University， Chongqing Key Laboratory of Infectious Disease Research， Chongqing 400038， China
- Publication Type:Journal Article
- Keywords:
Hepatitis Delta Virus;
Hepatitis D， Chronic;
Europe;
Practice Guideline
- From:
Journal of Clinical Hepatology
2023;39(11):2558-2563
- CountryChina
- Language:Chinese
-
Abstract:
Due to significant innovations in the diagnosis and treatment of hepatitis D virus （HDV）， the European Society of Hepatology （EASL） published its first international clinical practice guidelines on the management of individuals with HDV infection in July 2023. The guidelines mainly focus on the six aspects of HDV screening， diagnosis， clinical features and influencing factors， patient monitoring and selection for treatment， therapeutic methods and treatment endpoints. The guidelines give recommendations by answering and elaborating on 13 questions covering these six aspects. In addition， the guidelines also provide the prospect of the future treatment of HDV. The author’s team makes an excerpt of the guidelines and systematically introduces various evaluation points in recommendations and clinical management suggestions， in order to promote the development of clinical management and decision-making for individuals with HDV infection in China.
